Jan 27 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP - ANNOUNCES ADVANCEMENT OF PHASE II TRIAL FOR EFTILAGIMOD ALPHA IN COVID- 19 PATIENTS
Jan 27 (Reuters) - Immutep Ltd (IMM) : IMMUTEP - ANNOUNCES...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.050(17.0%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.0¢ | 33.5¢ | $2.128M | 6.004M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 82833 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 165786 | 8 |
View Market Depth
| Last trade - 10.31am 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |